PLXNA2 and cancer: The ovarian stemness marker OCT (octamer-binding transcription factor 4) is highly expressed in stem-like cancer populations in the malignant ascites of ovarian cancer patients [25] and has been shown to contribute to a chemoresistant and aggressive ovarian cancer phenotype [44].